⌘K
Timberlyne Therapeutics
Biopharmaceutical • Clinical-stage
Timberlyne Therapeutics is a biopharmaceutical company developing novel therapies for autoimmune disorders, focusing on advancing a monoclonal antibody targeting CD38.
Biopharmaceutical • Clinical-stage
Timberlyne Therapeutics is a biopharmaceutical company developing novel therapies for autoimmune disorders, focusing on advancing a monoclonal antibody targeting CD38.